Found: 98
Select item for more details and to access through your institution.
Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study.
- Published in:
- American Journal of Cardiovascular Drugs, 2018, v. 18, n. 1, p. 37, doi. 10.1007/s40256-017-0262-z
- By:
- Publication type:
- Article
5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure.
- Published in:
- BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/438403
- By:
- Publication type:
- Article
IRAG1 Deficient Mice Develop PKG1β Dependent Pulmonary Hypertension.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 10, p. 2280, doi. 10.3390/cells9102280
- By:
- Publication type:
- Article
TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2021, v. 11, n. 4, p. 1, doi. 10.1177/20458940211057071
- By:
- Publication type:
- Article
Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study.
- Published in:
- Pulmonary Circulation, 2020, v. 10, n. 4, p. 1, doi. 10.1177/2045894020973124
- By:
- Publication type:
- Article
Effect of riociguat on pulmonary arterial compliance in the PATENT and CHEST studies.
- Published in:
- Pulmonary Circulation, 2020, v. 10, n. 4, p. 1, doi. 10.1177/2045894020963836
- By:
- Publication type:
- Article
Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)
- Published in:
- Pulmonary Circulation, 2020, v. 10, n. 3, p. 1, doi. 10.1177/2045894020942121
- By:
- Publication type:
- Article
Impact of SARS‐CoV‐2 pandemic on pulmonary hypertension out‐patient clinics in Germany: a multi‐centre study.
- Published in:
- Pulmonary Circulation, 2020, v. 10, n. 3, p. 1, doi. 10.1177/2045894020941682
- By:
- Publication type:
- Article
Switching to riociguat: a potential treatment strategy for the management of CTEPH and PAH.
- Published in:
- Pulmonary Circulation, 2020, v. 10, n. 1, p. 1, doi. 10.1177/2045894019837849
- By:
- Publication type:
- Article
Enhanced circulating levels of CD3 cells-derived extracellular vesicles in different forms of pulmonary hypertension.
- Published in:
- Pulmonary Circulation, 2019, v. 9, n. 3, p. 1, doi. 10.1177/2045894019864357
- By:
- Publication type:
- Article
Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial.
- Published in:
- Pulmonary Circulation, 2018, v. 8, n. 4, p. 1, doi. 10.1177/2045894018798921
- By:
- Publication type:
- Article
Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT‐1/‐2 studies.
- Published in:
- Pulmonary Circulation, 2018, v. 8, n. 2, p. 1, doi. 10.1177/2045894018769305
- By:
- Publication type:
- Article
The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2017, v. 7, n. 2, p. 505, doi. 10.1177/2045893217706691
- By:
- Publication type:
- Article
Histological characterization of mast cell chymase in patients with pulmonary hypertension and chronic obstructive pulmonary disease.
- Published in:
- Pulmonary Circulation, 2014, v. 4, n. 1, p. 128, doi. 10.1086/675642
- By:
- Publication type:
- Article
Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193226
- By:
- Publication type:
- Article
Targeting Jak--Stat Signaling in Experimental Pulmonary Hypertension.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2021, v. 64, n. 1, p. 100, doi. 10.1165/rcmb.2019-0431OC
- By:
- Publication type:
- Article
Mitochondrial Hyperpolarization in Pulmonary Vascular Remodeling.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2013, v. 49, n. 3, p. 358, doi. 10.1165/rcmb.2012-0361OC
- By:
- Publication type:
- Article
Urodilatin, a Natriuretic Peptide Stimulating Particulate Guanylate Cyclase, and the Phosphodiesterase 5 Inhibitor Dipyridamole Attenuate Experimental Pulmonary Hypertension.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2001, v. 25, n. 2, p. 219
- By:
- Publication type:
- Article
Nitric Oxide (NO)--Dependent but Not NO-Independent Guanylate Cyclase Activation Attenuates Hypoxic Vasoconstriction in Rabbit Lungs.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2000, v. 23, n. 2, p. 222, doi. 10.1165/ajrcmb.23.2.3935
- By:
- Publication type:
- Article
Lung cancer-associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell-immune cell cross-talk.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 416, p. 1, doi. 10.1126/scitranslmed.aai9048
- By:
- Publication type:
- Article
A Novel Rat Model of Mild Pulmonary Hypertension Associated with Pulmonary Venous Congestion Induced by Left Pulmonary Vein Banding.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 5, p. 2827, doi. 10.3390/ijms25052827
- By:
- Publication type:
- Article
Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1502, doi. 10.3390/ijms22031502
- By:
- Publication type:
- Article
Genetic Deficiency and Pharmacological Stabilization of Mast Cells Ameliorate Pressure Overload-Induced Maladaptive Right Ventricular Remodeling in Mice.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 23, p. 9099, doi. 10.3390/ijms21239099
- By:
- Publication type:
- Article
The Prognostic Significance of Inspiratory Capacity in Pulmonary Arterial Hypertension.
- Published in:
- Respiration, 2014, v. 88, n. 1, p. 24, doi. 10.1159/000360481
- By:
- Publication type:
- Article
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10135-x
- By:
- Publication type:
- Article
Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.
- Published in:
- 2002
- By:
- Publication type:
- journal article
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)
- Published in:
- European Heart Journal, 2022, v. 43, n. 38, p. 3618, doi. 10.1093/eurheartj/ehac237
- By:
- Publication type:
- Article
Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study.
- Published in:
- European Heart Journal, 2022, v. 43, n. 36, p. 3387, doi. 10.1093/eurheartj/ehac206
- By:
- Publication type:
- Article
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors.
- Published in:
- Respiratory Research, 2005, v. 6, p. 76, doi. 10.1186/1465-9921-6-76
- By:
- Publication type:
- Article
Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration.
- Published in:
- Respiratory Research, 2005, v. 6, p. 128, doi. 10.1186/1465-9921-6-128
- By:
- Publication type:
- Article
The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 1, p. 205, doi. 10.1002/ejhf.2369
- By:
- Publication type:
- Article
Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489].
- Published in:
- 2016
- By:
- Publication type:
- journal article
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study.
- Published in:
- European Journal of Heart Failure. Supplements, 2022, v. 24, n. 1, p. 205, doi. 10.1002/ejhf.2369
- By:
- Publication type:
- Article
Response to: Comment on “Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding”.
- Published in:
- BioMed Research International, 2018, p. 1, doi. 10.1155/2018/7491284
- By:
- Publication type:
- Article
The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0043433
- By:
- Publication type:
- Article
Glycogen Synthase Kinase 3beta Contributes to Proliferation of Arterial Smooth Muscle Cells in Pulmonary Hypertension.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0018883
- By:
- Publication type:
- Article
Phosphodiesterase 10A Upregulation Contributes to Pulmonary Vascular Remodeling.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0018136
- By:
- Publication type:
- Article
Pulmonary Hypertension.
- Published in:
- Deutsches Ärzteblatt International, 2017, v. 114, n. 5, p. 73, doi. 10.3238/arztebl.2017.0073
- By:
- Publication type:
- Article
Single- versus Multiple-Beat Measurement of Right Ventricular Function in Rodents.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Effects of Multikinase inhibitors on pressure overload-induced right ventricular remodelling.
- Published in:
- 2013
- By:
- Publication type:
- Abstract
Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Poor sleep quality is associated with exercise limitation in precapillary pulmonary hypertension.
- Published in:
- BMC Pulmonary Medicine, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12890-015-0005-3
- By:
- Publication type:
- Article
FHL-1 is not involved in pressure overload-induced maladaptive right ventricular remodeling and dysfunction.
- Published in:
- Basic Research in Cardiology, 2020, v. 115, n. 2, p. 1, doi. 10.1007/s00395-019-0767-5
- By:
- Publication type:
- Article
The Role of Dimethylarginine Dimethylaminohydrolase in Idiopathic Pulmonary Fibrosis.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 87, p. 1, doi. 10.1126/scitranslmed.3001725
- By:
- Publication type:
- Article
Reply to Bogaard : Emphysema Is-at the Most-Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension.
- Published in:
- 2019
- By:
- Publication type:
- letter
Severe Emphysema in the SU5416/Hypoxia Rat Model of Pulmonary Hypertension.
- Published in:
- 2019
- By:
- Publication type:
- letter
More on Single-Beat Estimation of Right Ventriculoarterial Coupling in Pulmonary Arterial Hypertension.
- Published in:
- 2018
- By:
- Publication type:
- letter
Nintedanib in Severe Pulmonary Arterial Hypertension.
- Published in:
- 2018
- By:
- Publication type:
- letter